A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...

Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...

Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

The rationale for the study, according to the authors, is that “Nearly 2% of the US population received a prescription for ...

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...